Percheron Therapeutics
Business Services · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
l30 Collins Pl 35, Melbourne, Victoria, ...Phone Number
+61 398278999Website
www.percherontx.comRevenue
<$5 MillionStock Symbol
PERIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Percheron Therapeutics
Percheron Therapeutics is dedicated to developing innovative therapies for patients with rare diseases that have a high unmet medical need. The company aims to provide hope and improve patients' lives by harnessing cutting-edge science and partnering with world leaders to deliver impactful new medicines. Their product pipeline includes treatments for conditions like Duchenne muscular dystrophy (DMD), multiple sclerosis (MS), and acromegaly. The intended clients include patients suffering from these rare diseases, along with investors interested in the companys scientific advancements.Explore more
Percheron Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Percheron Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Percheron Therapeutics is spiking on competitors!
Earning: See what the market has to say on Percheron Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Percheron Therapeutics
Funding: Get notified immidiatlly once Percheron Therapeutics has new funding data
Click to see if Percheron Therapeutics had a recent Job posting/layoffs
Percheron Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Percheron Therapeutics launches new products
Check if Percheron Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Percheron Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Percheron Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Percheron Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Percheron Therapeutics.
Percheron Therapeutics financials insights
Gather financial insights about Percheron Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Other Financing Round
$2.2M
Percheron Therapeutics Tech Stack
A closer look at the technologies used by Percheron Therapeutics
See more technologies
Most Recent Scoops
Funding
Percheron Therapeutics has secured $2.2 million in additional funding. Investors were not disclosed.
Funding
Person-Based
Person-Based
Person-Based
Person-Based
Percheron Therapeutics News & Media
Percheron Therapeutics secures proposed WHO drug name for HMBD-002 cancer therapy
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has secured a proposed international nonproprietary name (pINN) from the World Health Organization for its investigational cancer therapy HMBD-002, another milestone as the company prepares the anti-VISTA immunotherapy for phase II...Percheron secures fresh funding to accelerate cancer therapy ambitions - Biotech Dispatch
The Melbourne-based company confirmed the successful completion of its entitlement offer, drawing strong backing from both existing shareholders and new investors eager to support the next phase of its work.Percheron opens entitlement offer to eligible shareholders
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has opened its non-renounceable pro rata entitlement offer to eligible shareholders, making the prospectus and personalised entitlement and acceptance forms available from today. The company said eligible shareholders have until 5:00pm AEST on...Small cap Watch: Small Caps continue to take care of business despite market volatility
The S&P/ASX Small Ordinaries Index (ASX: XSO) closed Friday at 3,384.20, down 42.60 points (1.24%), extending its decline to 142.60 points (4.04%) over the past five trading days as weakness across the small-cap sector weighed on sentiment. However, it's business as usual for reporting,...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Percheron Therapeutics
Sign Up For FreeTo access detailed company insights
Percheron Therapeutics is dedicated to developing innovative therapies for patients with rare diseases that have a high unmet medical need. The company aims to provide hope and improve patients' lives by harnessing cutting-edge science and partnering with world leaders to deliver impactful new medicines. Their product pipeline includes treatments f... Read More
